Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.
Clin Genitourin Cancer. 2018 Jun;16(3):e619-e627. doi: 10.1016/j.clgc.2017.10.015. Epub 2017 Nov 10.
The purpose of the present study was to investigate the association of smoking with biochemical recurrence (BCR) and metastasis in radiation-recurrent prostate cancer (PCa) patients undergoing salvage radical prostatectomy (SRP).
A total of 214 patients treated with SRP for radiation-recurrent PCa in 5 tertiary referral centers were included from January 2007 to December 2015. Kaplan-Meier analyses were used to assess the time to BCR and metastasis. Pre- and postoperative multivariable Cox proportional hazard regression models were fitted.
Overall, 120 (56.1%), 49 (22.9%), and 45 (21%) patients were never, former, and current smokers, respectively. Low-, medium-, and high-cumulative smoking exposure was registered in 59.8%, 16.4%, and 23.8% of cases, respectively. Patients with high cumulative smoking exposure had a significantly greater rate of a pathologic Gleason score of ≥ 8 (P = .01) and extracapsular extension (P = .004). Smoking status, cumulative smoking exposure, intensity, and duration were significantly associated with BCR-free survival (P < .001 for all). Smoking status, cumulative smoking exposure, and smoking intensity were significantly associated with metastasis-free survival (P = .03 for all). High cumulative smoking exposure was independently associated with BCR in both pre- (hazard ratio, 2.23; P = .001) and postoperative (hazard ratio, 1.64; P = .04) multivariable models adjusted for the effects of established clinicopathologic features. Smoking cessation did not affect either BCR- or metastasis-free survival (P = .56 and P = .40, respectively).
High cumulative smoking exposure was associated with the biologic and clinical aggressiveness of PCa in patients treated with SRP for radiation-recurrent disease. Smoking is a modifiable risk factor that detrimentally affected the outcomes, even in patients with advanced PCa.
本研究旨在探讨吸烟与接受挽救性前列腺根治切除术(SRP)治疗的放射性复发性前列腺癌(PCa)患者生化复发(BCR)和转移的相关性。
本研究共纳入 2007 年 1 月至 2015 年 12 月在 5 家三级转诊中心接受 SRP 治疗的 214 例放射性复发性 PCa 患者。采用 Kaplan-Meier 分析法评估 BCR 和转移时间。术前和术后多变量 Cox 比例风险回归模型进行拟合。
总体而言,120 例(56.1%)、49 例(22.9%)和 45 例(21%)患者分别为从不吸烟、曾经吸烟和当前吸烟。低、中、高累积吸烟暴露分别在 59.8%、16.4%和 23.8%的病例中登记。高累积吸烟暴露的患者病理 Gleason 评分≥8 的比例显著更高(P=0.01)和包膜外延伸(P=0.004)。吸烟状况、累积吸烟暴露、吸烟强度和吸烟持续时间与 BCR 无复发生存显著相关(P<0.001)。吸烟状况、累积吸烟暴露和吸烟强度与无转移生存显著相关(P=0.03)。高累积吸烟暴露与术前(风险比,2.23;P=0.001)和术后(风险比,1.64;P=0.04)多变量模型中均与 BCR 独立相关,这些模型均调整了既定临床病理特征的影响。戒烟对 BCR 或无转移生存无影响(P=0.56 和 P=0.40)。
高累积吸烟暴露与接受 SRP 治疗的放射性复发性疾病患者的 PCa 生物学和临床侵袭性相关。吸烟是一种可改变的危险因素,即使在晚期 PCa 患者中,也会对结局产生不利影响。